Wie sind die Öffnungszeiten?

Montag 09:00 - 17:00 Dienstag 09:00 - 17:00 Mittwoch 09:00 - 17:00 Donnerstag 09:00 - 17:00 Freitag 09:00 - 17:00

The_IASIOS

The International Accreditation System for Interventional Oncology Services (IASIOS)

18/06/2026

🧬 #𝗘𝗧𝟮𝟬𝟮𝟲 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲𝘀 𝗼𝗻 𝗙𝗿𝗶𝗱𝗮𝘆, 𝗝𝘂𝗻𝗲 𝟭𝟵, with IASIOS members contributing across a wide range of topics throughout the day:

• 𝗕𝗼𝗻𝗲: 𝗕𝗲𝘆𝗼𝗻𝗱 𝗠𝗦𝗞 | 🕘 09:00–10:00 | Dr. IJsbrand Zijlstra, Prof. Stavros Spiliopoulos

• 𝗩𝗲𝗻𝗼𝘂𝘀 𝗜𝗻𝘁𝗲𝗿𝘃𝗲𝗻𝘁𝗶𝗼𝗻𝘀 | 🕥 10:30–11:30 | Dr. Christiaan van der Leij, Dr. H. Saygin Tuna

• 𝗕𝗼𝗻𝗲: 𝗕𝗲𝘆𝗼𝗻𝗱 𝗠𝗦𝗞 | 🕛 12:00–13:00 | Dr. IJsbrand Zijlstra

• 𝗩𝗲𝗻𝗼𝘂𝘀 𝗜𝗻𝘁𝗲𝗿𝘃𝗲𝗻𝘁𝗶𝗼𝗻 | 🕛 12:00–13:00 | Dr. Christiaan van der Leij

• 𝗩𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗠𝗮𝗹𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 | 🕛 12:00–13:00 | Mr. Jan Jaap Janssen

• 𝗔𝗰𝘂𝘁𝗲 𝗕𝗹𝗲𝗲𝗱𝗶𝗻𝗴 | 🕝 14:30–15:30 | Dr. Tiago Pereira, Dr. Elisabeth Klompenhouwer

• 𝗔𝗜 𝗮𝗻𝗱 𝗥𝗼𝗯𝗼𝘁𝗶𝗰𝘀 | 🕟 16:30–17:30 | Dr. Elena Bozzi

Thank you to all faculty, participants, and organisers for contributing to another engaging day of scientific exchange and education.

18/06/2026

🎉 We are proud to celebrate CHUV | Lausanne university hospital becoming an IASIOS Accredited Centre!

👏 Congratulations to Prof. Rafael Duran and the entire interventional radiology and oncology team for their dedication to standardised, patient-centred care - this achievement is a true reflection of the work they put in every day for their patients.

Read the testimonial of Prof. Duran on how the accreditation process helped formalise workflows, strengthen team collaboration, and bring external recognition to the high standards already embedded in their daily practice 👇

Achieving Accredited Centre status means the interventional oncology patient pathway at Lausanne University Hospital complies with the core criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology, endorsed by more than forty international societies, reflecting a clear commitment to consistent, high-quality cancer care.

Want to know more about the standards used for accreditation? Click here: https://lnkd.in/eDUudwsa

17/06/2026

🧬 #𝗘𝗧𝟮𝟬𝟮𝟲 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲𝘀 𝘁𝗼𝗺𝗼𝗿𝗿𝗼𝘄! We're pleased to see IASIOS members contributing to Thursday's scientific programme:

• 𝗛𝗖𝗖 | 🕘 09:00–10:00 | Prof. Thomas Helmberger, Dr. Federico Collettini
• 𝗩𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗺𝗮𝗹𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻𝘀 | 🕥 10:30–11:30 | Prof. Wibke Uller, Dr Jan Jaap Janssen
• 𝗩𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗺𝗮𝗹𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻𝘀 | 🕛 12:00–13:00 | Dr Jan Jaap Janssen
• 𝗕𝗼𝗻𝗲: 𝗕𝗲𝘆𝗼𝗻𝗱 𝗠𝗦𝗞 | 🕛 12:00–13:00 | Dr. IJsbrand Zijlstra
• 𝗩𝗲𝗻𝗼𝘂𝘀 𝗶𝗻𝘁𝗲𝗿𝘃𝗲𝗻𝘁𝗶𝗼𝗻𝘀 | 🕛 12:00–13:00 | Dr. Christiaan van der Leij
• 𝗛𝗖𝗖 | 🕛 12:00–13:00 | Dr. Federico Collettini
• 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗶𝗺𝗮𝗴𝗶𝗻𝗴 𝗴𝘂𝗶𝗱𝗮𝗻𝗰𝗲 | 🕟 16:30–17:30 | Dr. Laurens Hermie, PD Dr. med. Timo Auer, Prof. Rosario Francesco Grasso, Prof. Mark Burgmans

We look forward to another day of learning, discussion, and knowledge exchange at ET2026.

16/06/2026

🧬 #𝗘𝗧𝟮𝟬𝟮𝟲 𝘀𝘁𝗮𝗿𝘁𝘀 𝘁𝗼𝗺𝗼𝗿𝗿𝗼𝘄! We're proud to see IASIOS members contributing to Wednesday's scientific programme:

• 𝗝𝗼𝗶𝗻𝘁𝘀: 𝗠𝗦𝗞 𝗲𝗺𝗯𝗼𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 | 🕘 09:00–10:00 | Dr. Florian Fleckenstein
• 𝗧𝗿𝗮𝘂𝗺𝗮 | 🕥 10:30–11:30 | Prof. Otto van Delden
• 𝗛𝗖𝗖 | 🕛 12:00–13:00 | Dr. Federico Collettini
• 𝗣𝗿𝗼𝘀𝘁𝗮𝘁𝗲 | 🕝 14:30–15:30 | Dr. Tiago Bilhim
• 𝗘𝗻𝗱𝗼𝗹𝗲𝗮𝗸 | 🕟 16:30–17:30 | Dr. Anna Maria Ierardi, Prof. Miltiadis Krokidis
We look forward to another inspiring edition of ET and to the exchange of knowledge that continues to advance embolotherapy worldwide.

15/06/2026

🎊 We are delighted to announce that King Khalid Hospital, from Najran, Saudi Arabia, has joined IASIOS as an Enrolled Centre.

Congratulations to Dr. Salem Alobaiyah, Dr.Nasser Algharem, Mr. Dhafer Al Bahri, Dr. Almotlaq, Dr Motared, and the wider team on taking this important step towards aligning their interventional oncology service with internationally recognised standards and structured quality assurance practices.

By joining IASIOS, the team becomes part of a growing international community committed to multidisciplinary collaboration, structured clinical pathways, and the delivery of safe, consistent, and high-quality interventional oncology care.

The continued growth of IASIOS in Saudi Arabia highlights the strong commitment of centres across the country to advancing quality assurance and strengthening interventional oncology services for patients. We are proud to welcome King Khalid Hospital to this growing community and look forward to supporting the team throughout their accreditation journey.

🌍 Interested in seeing the growing IASIOS community? Explore our network of more than 100 Enrolled, Accredited, and Centre of Excellence facilities here: https://www.iasios.org/facilities/

12/06/2026

⚓ As we look ahead to , we're looking forward to connecting with many of you in Copenhagen!

As part of the 𝗜𝗔𝗦𝗜𝗢𝗦 𝗔𝗻𝗻𝘂𝗮𝗹 𝗕𝗲𝗻𝗲𝗳𝗶𝘁𝘀 𝗣𝗿𝗼𝗴𝗿𝗮𝗺𝗺𝗲, members can take advantage of 𝘁𝘄𝗼 𝗰𝗼𝗺𝗽𝗹𝗶𝗺𝗲𝗻𝘁𝗮𝗿𝘆 𝗿𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻𝘀 for this year’s congress.

📩 To claim your free registrations, email [email protected].

11/06/2026

📣 𝗛𝗲𝗮𝗱𝗶𝗻𝗴 𝘁𝗼 𝗩𝗮𝗹𝗲𝗻𝗰𝗶𝗮 𝗳𝗼𝗿 𝗘𝗧 𝟮𝟬𝟮𝟲? The IASIOS team will be there from 17–20 June and would be delighted to meet you: https://meetings-eu1.hubspot.com/liam-gout/et2026 If you would like to discuss IASIOS accreditation, funding opportunities, or any questions related to interventional oncology quality assurance, you can book a dedicated meeting with our team in advance:

You are also warmly invited to visit the IASIOS booth throughout the congress to learn more about our accreditation programme, connect with the team, and discover how centres across the world are using IASIOS standards to strengthen their IO services.

We look forward to meeting you in Valencia!

10/06/2026

🎉 The IASIOS community is pleased to welcome Tirol Kliniken – Medizinische Universität Innsbruck from Innsbruck, Austria, as an IASIOS Enrolled Centre.

We warmly congratulate Prof. Reto Bale, Prof. Elke Gizewski, Prof. Alexander Loizides and the whole IR team for their commitment to aligning their interventional oncology service with internationally recognised standards and delivering high-quality patient care.

By joining IASIOS, the team becomes part of an international community dedicated to structured clinical pathways, multidisciplinary collaboration, and continuous quality improvement in interventional oncology. This milestone also marks the beginning of their pathway towards IASIOS accreditation.

With this addition, Austria continues to strengthen its presence within the IASIOS community. Tirol Kliniken – Medical University of Innsbruck becomes the second Austrian facility to join IASIOS, reflecting the growing commitment of Austrian centres to quality assurance and excellence in interventional oncology.

✨ Interested in how your centre can join IASIOS and begin the pathway toward accreditation? Learn more here: https://www.iasios.org/how-to-join/

09/06/2026

🎉 We are thrilled to announce a landmark achievement: Kwong Wah Hospital has become the first facility in Hong Kong to achieve IASIOS Accreditation!

This milestone reflects the hospital's full compliance with the rigorous international standards required for this recognition. IASIOS accreditation confirms that the interventional oncology service at Kwong Wah Hospital aligns with the CIRSE Standards of Quality Assurance in Interventional Oncology - a framework endorsed by more than forty international societies to support a comprehensive and safe approach to patient care.

By meeting the core requirements across staff and facilities, treatment planning and delivery, as well as safety and quality processes, the team has demonstrated an outstanding commitment to structured, high-quality care for cancer patients in Hong Kong and beyond.

👏 Our warmest congratulations go to Dr. Cho, Dr. Chan, Dr. Lo and the entire interventional radiology and oncology team at Kwong Wah Hospital for their dedication to standardised, patient-centred care and for making history for Hong Kong. We are incredibly proud to welcome you into the IASIOS community.

Interested in joining IASIOS? Enrol your facility today: https://www.iasios.org/enroll/register/

08/06/2026

🎊 The IASIOS community is pleased to welcome Mater Misericordiae University Hospital from Dublin, Ireland, as an IASIOS Enrolled Centre!

We warmly congratulate Dr. Michael Burns, Dr. Umer Salati, and the whole IR team for taking this important step towards strengthening structured, high-quality interventional oncology care.

As a recipient of the IASIOS First Year Forward Grant kindly made possible by Boston Scientific, the centre is joining a growing international community committed to quality assurance, multidisciplinary collaboration, and the delivery of safe and consistent IO care aligned with internationally recognised standards.

IASIOS enrolment marks the beginning of the pathway towards accreditation and supports centres in further developing structured clinical pathways and patient-centred cancer care.
We look forward to supporting the team throughout their IASIOS journey.

✨ Learn more about becoming an IASIOS Enrolled Centre: https://lnkd.in/dDKdyi-x

Adresse

Neutorgasse 9
Wien
1010

Öffnungszeiten

Montag	09:00 - 17:00
Dienstag	09:00 - 17:00
Mittwoch	09:00 - 17:00
Donnerstag	09:00 - 17:00
Freitag	09:00 - 17:00

Webseite

http://www.iasios.org/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von The_IASIOS erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.